skip to main content


Search for: All records

Creators/Authors contains: "Dutta, Ranjan"

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. β,β′-Phenylene bridged hexaphyrin[1.0.1.0.1.0] (naphthorosarin), an expanded porphyrin possessing C 3v -symmetry, has been shown to possess unique electronic features. We now report a bimetallic Rh( i )-complex of naphthorosarin retaining 24 π-antiaromatic characteristics. The two Rh( i ) cations reside on opposite sides of the macrocyclic π-system and are separated at a distance consistent with a possible Rh( i )–Rh( i ) metallic bond interaction. 
    more » « less
  2. The synthesis and characterization of the alkylidenyl-dibenzihexaphyrins bearing four indanedionyl groups at the meso -positions linked via four meso -exocyclic double bonds is reported. Treatment with trifluoroacetic acid at 50 °C leads to C(α)-protonation of the two indanedionyl groups resulting increased macrocyclic conjugation with dramatic red shifted absorption spectra. 
    more » « less
  3. Abstract

    Multiple sclerosis (MS) is a chronic inflammatory demyelinating and neurodegenerative disease of the central nervous system (CNS). The cause of MS is unknown, with no effective therapies available to halt the progressive neurological disability. Development of new and improvement of existing therapeutic strategies therefore require a better understanding of MS pathogenesis, especially during the progressive phase of the disease. This can be achieved through development of biomarkers that can help to identify disease pathophysiology and monitor disease progression. Proteomics is a powerful and promising tool to accelerate biomarker detection and contribute to novel therapeutics. In this review, an overview of how proteomic technology using CNS tissues and biofluids from MS patients has provided important clues to the pathogenesis of MS is provided. Current publications, pitfalls, as well as directions of future research involving proteomic approaches to understand the pathogenesis of MS are discussed.

     
    more » « less